GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr | ₹605 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹915 Cr |
| Mar2024 | ₹997 Cr |
| Mar2023 | ₹364 Cr |
| Mar2022 | ₹791 Cr |
| Mar2021 | ₹605 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹915 Cr | -8.23 | |
| Mar2024 | ₹997 Cr | 173.87 | |
| Mar2023 | ₹364 Cr | -53.97 | |
| Mar2022 | ₹791 Cr | 30.72 | |
| Mar2021 | ₹605 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,672.7 Cr | 2.3% | 3.6% | 11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.3% |
3.6% |
11.8% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses